US medical device maker Boston Scientific has reported an ongoing "global disruption" to its operations due to a cyberattack. The company, which manufactures medically implanted devices such as pacemakers and defibrillators, confirmed the incident in a filing with the U.S. Securities and Exchange Commission.
Boston Scientific stated that on Tuesday, it began experiencing "disruptions and limitations of access" to its critical IT systems and business applications. This has impacted its ability to ship and process orders.
The company has not yet confirmed whether the disruption extends to customers with medical devices and implants, nor has it provided details on the nature of the incident or what steps patients should take. An investigation is ongoing, and a timeline for restoring systems is not yet known.